What is the recommended treatment and management for a patient with scabies?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment and Management of Scabies

Apply permethrin 5% cream from the neck down (or entire body including scalp in infants and young children) for 8-14 hours, then wash off—this single application is generally curative. 1, 2, 3

First-Line Treatment Options

Topical Permethrin 5% Cream (Preferred)

  • Permethrin 5% cream is the CDC-recommended first-line treatment for all age groups, including infants, children, pregnant women, and lactating women. 1, 2
  • Apply to the entire body from the neck down in adults and older children (≥10 years or ≥15 kg). 1
  • In infants and young children (≤2 years), apply to the entire body including scalp, hairline, forehead, temples, and neck—this differs critically from adult application. 1
  • Leave on for 8-14 hours (typically overnight), then wash off thoroughly. 1, 2, 3
  • Usually 30 grams is sufficient for an average adult. 3
  • One application is generally curative; retreatment is only indicated after 2 weeks if live mites are observed or symptoms persist beyond 2 weeks. 1, 2, 3

Oral Ivermectin (Alternative First-Line)

  • Oral ivermectin 200 μg/kg is an effective alternative, repeated in 2 weeks. 1, 2
  • Must be taken with food to ensure adequate bioavailability and epidermal penetration. 1, 2
  • Contraindicated in children weighing <15 kg or younger than 10 years due to risk of neurotoxicity from blood-brain barrier penetration. 1, 2
  • Particularly useful when topical application is impractical (e.g., institutional outbreaks, extensive dermatitis, poor adherence). 1, 2

Special Populations

Pregnant and Lactating Women

  • Permethrin 5% cream is the preferred treatment due to limited safety data for ivermectin in pregnancy and lactation. 1, 2
  • Ivermectin is classified as "low risk" based on limited human data, but permethrin remains the primary recommendation. 2

Infants <2 Months Old

  • Permethrin can be considered for off-label use in infants <2 months. 1
  • Ivermectin is contraindicated due to potential neurotoxicity. 1
  • Apply permethrin to the entire body including scalp, face, and neck. 1

Crusted (Norwegian) Scabies

  • Requires aggressive combination therapy: topical permethrin 5% cream applied daily for 7 days, then twice weekly, PLUS oral ivermectin 200 μg/kg on days 1,2,8,9, and 15. 1, 2
  • Mandatory specialist consultation is required. 2
  • Occurs most frequently in immunocompromised, debilitated, or malnourished patients and harbors thousands to millions of mites. 2
  • Single-application permethrin or single-dose ivermectin alone will fail. 2
  • Affected patients should be isolated. 2

Contact and Environmental Management

Simultaneous Treatment of Contacts

  • All household members, sexual partners, and close contacts within the preceding month must be treated simultaneously, even if asymptomatic. 1, 2
  • Failure to treat asymptomatic contacts is the most common cause of treatment failure and reinfection. 1, 2
  • Scabies has a 4-6 week incubation period during which infected persons remain contagious despite being asymptomatic. 2

Environmental Decontamination

  • Machine-wash and dry all bedding, clothing, and towels using hot cycles, or dry-clean them. 1, 2
  • Alternatively, remove items from body contact for at least 72 hours (mites cannot survive off-host beyond 48-72 hours at room temperature). 1, 2
  • Fumigation of living areas is unnecessary and not recommended. 1, 2

Expected Post-Treatment Course

Normal Post-Treatment Symptoms

  • Pruritus and rash may persist for up to 2 weeks after successful treatment due to allergic dermatitis—this does NOT indicate treatment failure. 1, 2, 3
  • Approximately 75% of patients with persistent pruritus at 2 weeks will have complete resolution by 4 weeks. 3
  • Do not retreat based solely on persistent itching within the first 2 weeks. 1, 2

When to Retreat

  • Retreatment is indicated only after 2 weeks if:
    • Live mites are observed on examination 1, 2, 3
    • Symptoms persist beyond 2 weeks 1, 2
    • New lesions continue to appear 1
  • When retreating, switch to an alternative regimen (permethrin ↔ ivermectin). 2

Treatments to Avoid

Lindane

  • Never use lindane in children <10 years, pregnant or lactating women, or patients with extensive dermatitis due to high risk of neurotoxicity (seizures) and aplastic anemia. 1, 2
  • Applying lindane after bathing increases systemic absorption and toxicity—must be avoided. 1, 2
  • Lindane has the highest toxicity profile among scabicidal agents. 1

Topical Corticosteroids During Active Treatment

  • Do not apply triamcinolone or other topical corticosteroids during the permethrin or ivermectin treatment phase. 2
  • Corticosteroids suppress the inflammatory response that helps identify active infestation and may allow mites to proliferate. 2
  • Consider topical corticosteroids only after treatment completion if pruritus persists beyond 2 weeks AND live mites are confirmed absent. 2

Institutional Outbreak Management

  • Treat the entire at-risk population simultaneously. 1, 2
  • Mass oral ivermectin administration is recommended for ease of delivery in nursing homes, hospitals, and residential facilities. 1, 2
  • Coordinate outbreak response with a scabies specialist. 1, 2

Common Pitfalls to Avoid

  • Incomplete application of permethrin (missing under nails, between toes, in body folds, or genital areas). 1
  • Treating only the symptomatic index case while leaving asymptomatic household contacts untreated. 1, 2
  • Not repeating the ivermectin dose at 2 weeks. 2
  • Premature retreatment within 2 weeks based solely on persistent itching. 1, 2
  • Incomplete environmental decontamination of bedding and clothing. 2
  • Using lindane in contraindicated populations or after bathing. 1, 2

References

Guideline

Scabies Management in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Scabies Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.